Coloplast A/S (OTCMKTS:CLPBY) Reaches New 52-Week Low – Here’s Why

Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) hit a new 52-week low on Monday . The stock traded as low as $6.98 and last traded at $6.99, with a volume of 45100 shares. The stock had previously closed at $7.24.

Analyst Ratings Changes

Separately, Sanford C. Bernstein raised shares of Coloplast A/S to a “hold” rating in a research report on Wednesday, January 28th. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Coloplast A/S presently has an average rating of “Hold”.

Coloplast A/S Stock Performance

The stock’s 50-day moving average price is $8.13 and its 200-day moving average price is $8.77. The company has a current ratio of 1.30, a quick ratio of 0.81 and a debt-to-equity ratio of 1.50. The company has a market capitalization of $16.02 billion, a P/E ratio of 26.33, a P/E/G ratio of 0.72 and a beta of 0.33.

Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earnings data on Friday, February 6th. The company reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.09 by $0.01. The business had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.12 billion. Coloplast A/S had a net margin of 14.35% and a return on equity of 27.87%. As a group, equities analysts expect that Coloplast A/S Sponsored ADR will post 0.31 EPS for the current year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.